Brentview Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.28M Buy
28,682
+941
+3% +$219K 2.88% 12
2026
Q1
$6.78M Buy
27,741
+1,144
+4% +$266K 2.93% 9
2025
Q4
$5.5M Buy
26,597
+331
+1% +$65.5K 2.49% 18
2025
Q3
$4.87M Buy
26,266
+5,337
+26% +$914K 2.22% 22
2025
Q2
$3.2M Sell
20,929
-427
-2% -$65.6K 1.61% 34
2025
Q1
$3.54M Buy
21,356
+1,227
+6% +$192K 1.88% 32
2024
Q4
$2.91M Buy
+20,129
New +$3.12M 1.65% 33

Other funds holding JNJ

Brentview Investment Management's JNJ Position: Q2 2026 in Review

Brentview Investment Management increased its Johnson & Johnson (JNJ) stake by 3.4% in Q2 2026, buying an estimated $219K and bringing the position to 28,682 shares worth $7.28M. The position accounts for 2.88% of the portfolio, ranked #12.

Brentview Investment Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Brentview Investment Management held 28,682 shares of Johnson & Johnson worth $7.28M as of Q2 2026.
  • Brentview Investment Management bought 941 Johnson & Johnson shares in Q2 2026, an estimated $219K.
  • Johnson & Johnson made up 2.88% of Brentview Investment Management's portfolio in Q2 2026, its #12 holding.
  • Brentview Investment Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Brentview Investment Management's 13F filing for Q2 2026, filed 30 Jul 2026.